Most Read Articles
6 days ago
Ivermectin confers benefits in the treatment of COVID-19, with a recent study showing that its use helps reduce the risk of death especially in patients with severe pulmonary involvement.
6 days ago
Mental health comorbidities are common among patients with type 2 diabetes mellitus and may lead to worse outcomes, a recent study has found.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

3 days ago
Vitamin D deficiency may be a contributing factor to the mortality rate among patients with the novel coronavirus disease (COVID-19), reports a new study.

Abnormal liver function in COVID-19 tied to longer hospital stay

17 Apr 2020

Patients with coronavirus disease 2019 (COVID-19) may present with abnormal liver function, which in turn is associated with longer hospital stay, a study reports.

Researchers looked at 148 consecutive patients (mean age, 50 years; 50.68 percent male) admitted at the Shanghai Public Health Clinical Center from January 20 through 31, evaluating patient outcomes until February 19. Abnormal liver function was defined as elevation in concentrations of alanine and aspartate aminotransferase, gamma glutamyltransferase, alkaline phosphatase, and total bilirubin.

Fifty-five COVID-19 patients presented with abnormal liver function at hospital admission. Most of these patients were men and had higher levels of procalcitonin and C-reactive protein.

Significantly more patients in the abnormal liver function group had high fever than in the group with normal liver function (14.5 percent vs 4.3 percent; p=0.027). There was no between-group difference in medications taken before hospitalization, although a markedly higher proportion of patients in the former group had received lopinavir/ritonavir after admission (57.8 percent vs 31.3 percent).

Mean hospital stay was significantly longer in the group of patients with abnormal liver function than in those with normal liver function (15.09 vs 12.76 days; p=0.021).

The researchers explained that SARS-CoV-2, the causative agent for COVID-19, potentially causes liver function damage and that liver injury following admission may be associated with the use of lopinavir/ritonavir. These data may guide clinical treatment of patients during the current pandemic.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
6 days ago
Ivermectin confers benefits in the treatment of COVID-19, with a recent study showing that its use helps reduce the risk of death especially in patients with severe pulmonary involvement.
6 days ago
Mental health comorbidities are common among patients with type 2 diabetes mellitus and may lead to worse outcomes, a recent study has found.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

3 days ago
Vitamin D deficiency may be a contributing factor to the mortality rate among patients with the novel coronavirus disease (COVID-19), reports a new study.